The AML cell line Kasumi-1 appears to be more sensitive to either SRPK1 inhibition by SPHINX or SRPK1 knockdown compared to the CML cell line K562. Here, SRPK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.